HeyJaredErik Swain
- Indexed articles, last 90 days
- 23
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Healio
- Top 500K sites
- Earliest in this view
- Jul 10, 2026
Latest articles
Camzyos receives new indication to treat certain pediatric patients with obstructive HCM (opens the original)
Read excerpt
The FDA approved a new indication for mavacamten, extending its approval to include certain pediatric patients with obstructive hypertrophic cardiomyopathy, Bristol Myers Squibb announced. Mavacamten (Camzyos) is now indicated for adult and pediatric patients with obstructive HCM weighing 30 kg (66 lb) or more, according to a company press release. It was first approved in 2022 for adults with obstructive HCM. Approval for the new indication was based on results of the SCOUT-HCM trial, in which,
Novel amylin drug confers 10% weight loss with adverse events comparable to placebo (opens the original)
Read excerpt
Petrelintide, a novel amylin analog, was associated with up to 10% weight loss with a comparable adverse events profile to placebo at 28 and 42 weeks, according to results of the ZUPREME 1 phase 2 trial. For the trial, presented at the European Association for the Study of Diabetes annual meeting and simultaneously published in The Lancet Diabetes & Endocrinology, the researchers analyzed data from 485 patients (mean age, 47 years; 53% women; 86% white) with overweight or obesity (BMI 30 kg/m2 o
Retriever thrombectomy reduces infarct size in STEMI, large thrombus burden (opens the original)
Read excerpt
MUNICH — Stent retriever thrombectomy followed by percutaneous coronary intervention reduced infarct size compared with conventional PCI alone in patients with STEMI and large thrombus burden, researchers reported. For the NATURE trial — the results of which were presented at the European Society of Cardiology Congress and simultaneously published in the Journal of the American College of Cardiology — Marco Valgimigli, MD, PhD, head of cardiology at Istituto Cardiocentro Ticino in Lugano, Switze
Digital outreach strategy raises statin refills in nonadherent patients (opens the original)
Read excerpt
MUNICH â In patients indicated for statin therapy who were recently nonadherent, a digital outreach strategy improved refill rates compared with the usual communication, researchers reported at the European Society of Cardiology Congress. However, most patients did not refill their statin prescription, according to a presentation. The ADHERE-ASCVD study, simultaneously published in JAMA, included 20,604 patients (mean age, 55 years; 41% women) from the Kaiser Permanente Northern California hea
Routine coronary CTA does not improve outcomes in patients with chest pain but no MI (opens the original)
Read excerpt
MUNICH â In patients with acute chest pain ruled out for MI, route coronary CT angiography did not reduce risk for subsequent MI or CV death compared with standard care, according to results of the TARGET-CTCA trial. For the trial, presented at the European Society of Cardiology Congress and simultaneously published in The New England Journal of Medicine, researchers randomly assigned 3,170 patients (median age, 61 years; 30.2% women) from 14 U.K. hospitals who presented with acute chest pain,
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Healio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.